Effects of a serotonin S2-receptor blocker on Healing of acute and chronic tendon injuries

Journal of Investigative Surgery

Volumn 22, Issue 4, 2009, Pages 246-255

  Oryan, Ahmad ^a   Silver, Ian A ^b   Goodship, Allen E ^c  

^a SHIRAZ UNIVERSITY   (Iran)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biomechanics; Metrenperone; Morphology; S2 receptor blocker; Tendon healing; Ultrastructure

Indexed keywords

COLLAGENASE; METRENPERONE; SEROTONIN 2 ANTAGONIST; UNCLASSIFIED DRUG; PIPERIDINE DERIVATIVE; SEROTONIN 2 RECEPTOR; SEROTONIN ANTAGONIST;

ACUTE DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; COLLAGEN METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; FLEXOR TENDON; HEALING; NONHUMAN; PRIORITY JOURNAL; RABBIT; TENDON INJURY; THERAPY DELAY; TISSUE REPAIR; ANIMAL; BIOMECHANICS; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; ORAL DRUG ADMINISTRATION; PATHOLOGY; TENDON; TOPICAL DRUG ADMINISTRATION; WOUND HEALING;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ANIMALS; BIOMECHANICS; FEMALE; PIPERIDINES; RABBITS; RECEPTORS, SEROTONIN, 5-HT2; SEROTONIN ANTAGONISTS; TENDON INJURIES; TENDONS; WOUND HEALING;

EID: 73949090782     PISSN: 08941939     EISSN: 15210553     Source Type: Journal    
DOI: 10.1080/08941930903040114     Document Type: Article

References (35)

1. Goodship AE, Birch HL, Wilson AM. The pathobiology and repair of tendon and ligament injury. Vet Clin North Am, Equine Pract. 1994;10:323-349.
2. Graham HK, Holmes DF, Watson RB, et al. Identification of collagen fibril fusion during vertebrate tendonimorphogenesis. The process relies on unipolar fibrils and is regulated by collagen-proteoglycan interaction. J Mol Biol. 2000;295:891-902.
3. Birk DE, Zycband E. Assembly of the tendon extracellular matrix during development. J Anat. 1994;184:457-463.
4. Oryan A. Role of collagen in soft connective tissue wound healing. Transplant Proc. 1995;27:2759-2761.
5. Frank C, McDonald D, Bray D, et al. Collagen fibril diameters in the healing adult rabbit medial collateral ligament. Connect Tissue Res. 1992;27:251-263.
6. Tureck SL. Orthopaedics Principles and their Applications. Philadelphia: J. B. Lippincott Company; 1994:997-998.
7. Oryan A, Peyghan R. Morphological and biomechanical characteristics of tendons and ligaments. J Vet School Tehran Univ. 1996;50:13-38.
8. Silver IA, Brown PN, Goodship AE, et al. A clinical and experimental study of tendon injury, healing and treatment in horse. Equine Vet J. 1983;Suppl. 1:1-43.
9. Knighton DR, Silver IA, Hunt TK. Regulation of wound healing angiogenesis: effect of oxygen gradients and inspired oxygen concentration. Surgery. 1981;90:262-270.
10. Hara H, Osakabe M, Kitajima A, et al. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist. Thromb Haemost. 1991;65:415-420.
11. Hood S, Birnie D, NasserA, et al. Effects of ketanserin on central haemodynamics and coronary circulation. J Cardiovasc Pharm. 1998;32:983-987.
12. Verbeke M, Van de Voode J, de Ridder L, et al. Influence of ketanserin on experimental loss of renal blood flow autoregulation. Kidney Int Suppl. 1998;76:S238-S241.
13. Banga FR, Bolte AC, Dekker GA, et al. Ketanserin in women with chronic hypertension and underlying thrombophilia. Obstet Gynecol. 2004;103:1084-1087.
14. Verheyen A, Vlaminckx E, Remeysen P, et al. The influence of ketanserin, a new S2-receptor antagonist, on experimentallyinduced skeletal muscle myopathy in the rat. Virchows Arch. 1981;393:265-272.
15. Achouche J, Teisseire B, Laccourreye O, et al. Ketanserin and random skin flaps: an experimental study in the rat. Ann Chir Plast Esthet. 1994;39:239-244.
16. Zielanowski MM. Topical ketanserin gel for anal fissure: an open-label, prospective study. Adv Ther. 2000;17:27-31.
17. Salazar JJ, Serrano GG, Leon-Quintero GI, et al. Use of topical ketanserin for the treatment of ulcers in leprosy patients. Indian J Leprosy. 2001;73:103-110.
18. Martinez-de-Jesus FR, Morales-Guzman M, Catsneda M, et al. Randomized single-blind trial of topical ketanserin for healing acceleration of diabetic foot ulcers. Arch Med Res. 1997;28:95-99.
19. Quatresooz P, Kharfi M, Paquet P, et al. Healing effect of ketanserin on chronic leg ulcers in patients with diabetes. J Eur Acad Dermatol Venereol. 2006;20:277-281.
20. Janssen PAJ. 5-HT2 receptor blockade to study serotonininduced pathology. Trends Pharmacol Sci. 1983;198-206.
21. Linden A, DesmechtD,AmoryH, et al. Cardiovascular response to intravenous administration of 5-Hydroxytryptamine after type-2 receptor blockade, by metrenperone, in healthy calves. Vet J. 1999;157:31-37.
22. Walker RT, Matrai A, Bogar L, et al. Effects of ketanserin on the intercellular concentration and transmembrane fluxes of sodium and potassium in erythrocytes of normal male subjects. J Cardiovasc Pharm. 1985;7(Suppl. 1):35-40.
23. Woessner JF. The determination of hydroxyproline in tissues and protein samples containing small proportions of this amino acid. Arch Biochem Biophys. 1961;93:440-447.
24. Williams IF,McCullagh KG, Silver IA. The distribution of types I and III collagen and fibronectin in the healing equine tendon. Connect Tissue Res. 1984;12:211-227.
25. Vailas AC, Tipton CM, Matthes RD, et al. Physical activity and its influence on the repair process ofmedial collateral ligaments. Connect Tissue Res. 1981;9:25-31.
26. Woo SL-Y, Ritter MA, Amiel D, et al. The biomechanical and biochemical properties of swine tendons-long term effects of exercise on the digital extensors. Connect Tissue Res. 1980;7:177-183.
27. RiemersmaDJ, SchamhardtHC. The cryo-jaw, a clamp designed for in vitro rheology studies of horse digital flexor tendons. J Biomech. 1982;15:619-620.
28. Silver FH, Freeman JW, Seehra GP. Collagen self-assembly and the development of tendon mechanical properties. J Biomech. 2003;36:1529-1553.
29. Craig AS, Birtles MJ, Conway JF, et al. An estimate of the mean length of collagen fibrils in rat tail tendon as a function of age. Connect Tissue Res. 1989;19:51-62.
30. Provenzano PP, Vanderby RJ. Collagen fibril morphology and organization: implications for force transmission in ligament and tendon. Matrix Biol. 2006;25:71-84.
31. Hashemi J, Chandrashekar N, Slauterbeck J. The mechanical properties of the human patellar tendon are correlated to its mass density and are independent of sex. Clin Biomech. 2005;20:645-652.
32. Oryan A, Peyghan R, EmamiMJ. The effects of physical activity on tendon healing. Iranian J Med Sci. 1993;18:13-20.
33. Oryan A, Shoushtari AH. Histology and ultrastructure of the developing Superficial Digital Flexor Tendon in rabbits. Anat Histol Embryol. 2008;37:134-140.
34. Paterson-Kane JA, Firth EC, Goodship AE, et al. Age-related differences in collagen crimp patterns in the superficial digital flexor tendon core region of untrained horses. Aust Vet J. 1997;75:39-44.
35. Zhang G, Young BB, Ezura Y, et al. Development of tendon structure and function: regulation of collagen fibrillogenesis. J Musculoskelet Neuronal Interact. 2005;5:5-21.